touchONCOLOGY joins Dr Scott Shepherd (London, UK), to discuss his presentation at ESMO 2021 on the CAPTURE study exploring adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients. To view Part Two click here.
Questions
1. What were the aims and design of the CAPTURE study? (00:18-02:25)
2. What were the study findings in the infection cohort? (02:25-04:31)
3. What were the study findings in the vaccinated cohort? (04:31-07:18)
Disclosures: Scott Shepherd has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.
Filmed in coverage of the ESMO 2021 Annual Meeting.
